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HARM REDUCTION PROGRAMS - WEST VIRGINIA VS. UNITED STATES
ABSTRACT
Introduction: Harm reduction has been a movement for social justice built on a belief in, and
respect for, the rights of people who use drugs. It has been defined as a set of practical strategies
and ideas aimed at reducing negative consequences associated with drug use. The U.S. has been
experiencing an opioid/heroin epidemic, with significant increases in overdose death among drug
users with more than 72,000 Americans having died from drug overdoses in 2017.
Methodology: The methodology for this study was a literature review with a semi structured
interview with Tina Rameriz of the Kanawha-Charleston Health Department in Charleston, West
Virginia. The electronic databases used included EBSCOhost, PubMed, Academic Search
Premier, ProQuest, and Google Scholar. Government and medical websites were also used. A
total of 47 sources were referenced.
Results: The results of the literature review showed that West Virginia had the highest ageadjusted rate of drug related overdose deaths in the nation in 2014. Overdoses claimed more than
three out of every 100 fatalities and ranked #1 in drug overdose deaths with a rate of 41.5 deaths
per 100,000 people in 2015. West Virginia had a statewide Harm Reduction Coalition that
provided support and guidance for any agency interested. States such as Minnesota, North
Carolina and Ohio have had better results in implementing harm reduction programs. An
opportunity of harm reduction programs was the creation of the drug Naloxone.
Discussion/Conclusion: This research was not without its limitations. The review suggested that
West Virginia has been in fact, behind other states in the U.S. By utilizing several harm
reduction programs in the state of West Virginia, this would also create a substantial decrease in
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the number of HIV and Hepatitis virus spread through needle sharing among injection drug
users.
Key Words: harm reduction programs, hepatitis, program implementation, syringe exchange
programs, United States, West Virginia.
INTRODUCTION
Harm reduction has been defined a set of practical strategies and ideas aimed at reducing
negative consequences associated with drug use (Harm Reduction Coalition, 2018a). Harm
Reduction has been also a movement for social justice built on a belief in, and respect for, the
rights of people who use drugs (Advance Access & Delivery, 2018). Drug overdose death rates
have increased steadily from 1999 to 2016, with more than 200,000 people having died in the
United States, especially in parts of West Virginia (Wheeler, Davidson, Jones, & Irwin, 2012).
It was not until the late 1980’s that syringe exchange programs began at the state and
local level in the United States (U.S.),with funding primarily from state and local governments
and the support of the North American Syringe Exchange Network. There were approximately
200 programs for syringe exchange in the U.S in 2015. (Des Jarlais, 2017). The programs have
been shown to save $738 million in health care costs for drug users because they do not need
HIV treatment, and have also reduced the risk to the public of accidentally pricking themselves
with a discarded needle (Vestal, 2016).
States have been responsible for creating their own laws regarding syringe access, and
syringes that can currently be purchased over the counter without a prescription (Bonner, 2015).
As of 2016, only 18 states have state laws that explicitly authorize syringe exchange (Shatter
Proof, 2018).
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The U.S. has been experiencing an opioid/heroin epidemic, with significant increases in
overdose deaths among drug users with more than 72,000 Americans having died from drug
overdoses in 2017 (NIH, 2018a). Much of this epidemic has been occurring in suburban and
rural of the country without harm reduction services (Des Jarlais, 2017). Drug overdose has been
the leading cause of accidental death in the U.S., with 52,404 lethal drug overdoses in 2015.
Opioid addiction has been driving this epidemic, with 20,101 overdose deaths related to
prescription pain relievers, and 12,990 overdose deaths related to heroin in 2015 (Advance
Access & Delivery, 2018).
In 2018, a study conducted by the West Virginia Department of Health and Human
Resources identified 28 counties in West Virginia as high risk for rapid dissemination of HIV
and hepatitis C among people who have injected drugs (Bernardino, 2018). Increasing access to
Harm Reduction Programs in high-risk areas have reduced new viral hepatitis and HIV cases by
5.8%, by decreasing the sharing of syringes and other injection equipment (WV DHHR, 2018).
Harm reductions have been proven to be expensive to run effectively. The costs of
conducting harm reduction programs have continued to vary from health department to health
department and state to state, estimated to range from $23–71 per person per year, depending on
factors such as the number of patients and the number of services provided beyond syringe
exchange (WVALHD, 2016). Harm reduction interventions have been a good value for the funds
invested and improved health outcomes for people who inject drugs, including the broader
population; although scaling up has been costly (Wilson, Donald, Shattock, Wilson, & FraserHunt, 2015).

3

M. Belcher, H. Sayre – December 13, 2018 – HCA 695 – Draft 3 – Dr. Coustasse
The purpose of this research was to analyze the success of harm reduction programs in
West Virginia in relation to the population of the United States as a whole and to determine if
there has been a HIV and Hepatitis reduction.
METHODOLOGY
The primary hypothesis of this study was that West Virginia did not have a successful harm
reduction program in comparison to other states in the United States. The mixed methodology
for this qualitative study was a literature review, complemented with a semi structured interview
through electronic communication (e-mail), after an Institutional Review Board (IRB) approval.
Tina Rameriz of the Kanawha-Charleston Health Department in Charleston, West Virginia was
consulted as an expert in harm reduction (Appendix). The literature that was utilized in this study
encompassed primary and secondary data. The literature review was conducted in three
individual stages involving: (1) developing a search strategy and gathering data for the case
study; (2) determining and analyzing the relevant literature; (3) categorizing literature.
Step 1: Literature Identification and Collection
The electronic databases used include EBSCOhost, PubMed, Academic Search Premier,
ProQuest, and Google Scholar. The terms searched within each database were: “harm reduction
programs” OR “syringe exchange programs,” AND “West Virginia” AND “United States,” OR
“program implementation” OR “hepatitis”. Journals cited included but were not limited to:
Harm Reduction Journal, North Carolina Medical Journal, Substance Use and Misuse, and other
reliable medical and government websites. Following a PRISMA approach, the search identified
relevant citations and articles were excluded (N=142) if they did not meet inclusion principles.
Articles were included (N=47) if they described harm reduction programs in the United States
and/or West Virginia: articles from other sources (N=19) were also included in this search. These
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references were subject to full-text review, and these citations were included in the data
abstraction and analysis. Only references were used in results section (see Figure 3).
Step 2: Literature Analysis
In attempt to collect the most recent data, sources older than 10 years, 2008 or earlier,
were removed from the search and only sources written in English were used. Primary and
secondary data from articles, literature reviews, research studies, and reports written in the U.S.
were included in this research. The literature review included 47 references, which were
assessed for information pertaining to this research project. The literature search conducted by
MB, HS, and validated by AC, who acted as second reader and double checked to ensure that
references met the inclusion criteria. A conceptual framework for the success of harm reduction
programs was created by the authors based on trends, efficiency, barriers, and opportunities.
Step 3: Literature Categorization
The following subheadings were categorized into results: West Virginia Harm Reduction
Programs, Harm Reduction Programs in the United States, and Barriers and Opportunities of
Harm Reduction Programs.
RESULTS
West Virginia Harm Reduction Programs
According to the U.S. Census Bureau, West Virginia had the highest age-adjusted rate of
drug related overdose deaths in the nation in 2014; 35.5 per 2,000 (CDC, 2018). In 2015 in West
Virginia, overdoses claimed more than three out of every 100 fatalities and ranked #1 in drug
overdose deaths with a rate of 41.5 deaths per 100,000 people (Ingraham, 2017). Among certain
demographic groups, which included white males age 15 to 34, the likelihood of overdose was
much higher at 28%, with overdoses typically occurring with younger individuals, ages 20-29
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(Ingraham, 2017). Since March 2018, the West Virginia Bureau for Public Health has reported
an increase in the number of confirmed cases of acute Hepatitis A virus. Figure 1 and Figure 2
showed the state of West Virginia with cases reported and the demographics of the individuals
affected. 1225 cases which were 59.8% male were reported in Figure 1. This increase in cases
has primarily been reported among injection and non-injection drug users, homeless or mobile
individuals, and those who have been recently incarcerated; viral sequencing has linked cases
from Kentucky and California as well (Fleming, 2018).
The locations of syringe exchange programs that have been listed on the North American
Syringe Exchange Network reported ten syringe exchange programs for the state of West
Virginia (NASEN, 2018). According to NASEN, the programs listed included but were not
limited to; Charleston, Clarksburg, Fayetteville, Huntington, Brooke and Hancock Counties,
Morgantown, Vienna, Weston, and Wheeling. The counties have shown the need for even more
harm reduction and syringe exchange programs in the state to serve the vulnerable population.
The Wheeling-Ohio County program has limited the number of needles to 20 per visit and has
also provided limited additional supplies such as condoms and alcohol prep pads to help prevent
additional issues (Comins, 2018). There is a West Virginia statewide Harm Reduction Coalition
that provides support and guidance for any agency that is interested in harm reduction (T.
Rameriz, interview, 2018).
In March 2018, Brenda Isaac, president of the Kanawha-Charleston Board of Health,
announced that the Kanawha-Charleston Health Department was suspending the needle
exchange portion of its harm reduction program, due to failure to build and maintain community
support and lack of data informing of other harm reduction services, which was effective
immediately (Kersey & Beck, 2018). As shown in Figure 1, Kanawha County who according to
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statistics had a population of 193,063 in 2017, had over 350 confirmed cases of hepatitis related
to drug use (Suburban Stats, 2018). According to the WVDHHR, five counties; Cabell,
Kanawha, Putnam, Raleigh, and Wood, accounted for 55% of state’s acute Hepatitis case burden.
Unfortunately, the syringe exchange program for the Kanawha-Charleston Health Department
has no plans of being reinstated (Kersey, 2018).
WV Health Right, Inc. located in Charleston, West Virginia, has offered a full range of
substance abuse disorder treatment services. These services have included; full harm reduction
services such as physical exams, vaccines, testing for Hepatitis A,B, C and HIV, Naloxone
education and training, syringe exchange program, therapy, a psychiatrist on-site as needed, as
well as referral for Medication-Assisted Treatment (West Virginia Health Right, 2018).
Harm Reduction Programs in the United States
States such as Minnesota, North Carolina, and Ohio, have had better results in relation to
the implementation of harm reduction programs (Corso & Townley, 2016). The state of North
Carolina have adopted several techniques and programs relating to harm reduction (Bartlett,
Brown, Shattell, Wright, Lewallen, 2013). These techniques have included but were not limited
to; medication-assisted treatment, overdose prevention training for people impacted by drug use
and first responders, pre-arrest diversion programs, HIV and Hepatitis C testing, laws that protect
people who call 911 to report an overdose, and expansion of substance use treatment programs
(Castillo, 2018). As of February 2018, North Carolina had 26 syringe exchange programs
throughout the state in diverse locations such as bookstores, pawn shops, churches, fire
departments, health departments, AIDS services organizations, and drug user unions (Castillo,
2018).
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Minnesota had syringe access and disposal via pharmacies and syringe services programs
(Just Us Health, 2018). The needle exchange program in Minnesota, which started with Women
With a Point, has continued on to a home delivery service, passing out 10,000 syringes in the
first year and 200,000 in the next four years (MN Department of Health, 2018). The Ohio
legislature approved needle exchanges in a 2015 budget bill, which has allowed local health
departments to make decisions without going to the state (DeVito, 2018). Syringe Exchange
Programs have repeatedly been shown to be cost-effective and according to a 2005 Centers for
Disease Control and Prevention study, the cost to prevent one HIV infection by SEPs has been
calculated at $4,000–$12,000 (AIDS Watch, 2014).
Since 2015, safer drug use consumption services (SCS) participants have gained access to
other medical and social services and entry into drug treatment (Hodel, 2017). There had not
been a single overdose death involving SCS participants in any of these programs over 10 years
of operation and millions of supervised injections (Drug Policy Alliance, 2018). SCS did not
increase drug use in the area, nor did they encourage young people to initiate drug use; and crime
and public nuisance decreased in the areas around these programs (Raymond, 2017).
Barriers and Opportunities of Harm Reduction Programs
There have been both barriers and opportunities of harm reduction programs. Barriers
have included: anticipated negative community reaction to needle exchange, methadone
treatment, free condoms, lack of staff and funding, and anticipated staff resistance (Hunt, 2010).
Qualitative interviews with people who injected drugs found a number of reported barriers to
safer risk reduction which included withdrawal, craving, limited access to sterile injection
equipment, cost associated with injection equipment, time pressures, not being organized in
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advance, legal reasons, and fear of rejection from fellow injectors if sharing (Phillips, Altman,
Corsi, & Stein, 2012).
Some places in various states that have established syringe exchanges have now
reconsidered it, worried that syringe exchange programs may bring crime into their communities
or that local efforts have helped people from other counties or states (Meehan, 2018). Some
programs have only wanted to distribute retractable needles, but communities have been
concerned that this was potentially not the best practice (Harris, 2016). Retractable needles have
meant to be used one time, once the needle is retracted, it cannot be used again. That practice
often has been not realistic for drug users who shoot up several times per day because without
ready access to multiple needles, they were likely to use the same one more than once (Lilly,
2018).
There have been also multiple opportunities that were present in harm reduction
programs. Multiple opportunities for harm reduction strategies to minimize the morbidity and
mortality associated with opioid abuse and dependence, have included; targeted overdose
education, naloxone distribution, and policies to increase bystander assistance in the case of an
overdose (Hawk, Vaca, & D’Onofrio, 2015). Collaboration on opioid overdose prevention gave
prevention and harm reduction fields and workers opportunities to develop that common
vocabulary and have a better understanding of activities, priorities, and knowledge (Stancliff &
Raymond, 2017). The syringe exchange program has been a way for clinics to meet with people
and try to help them be safer by not sharing needles (Dean, 2018).
A huge opportunity of harm reduction programs was the creation of the drug Naloxone.
Naloxone has been a medication designed to reverse opioid overdose quickly; it is an antagonist,
meaning it binds to opioid receptors and can reverse and block the effects of other opioids (NIH,
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2018b). Naloxone, also known as Narcan only worked if a person has opioids in their system. It
is traditionally administered by emergency response personnel, but also minimally trained laypeople, which makes it ideal for treating overdose in people who have been prescribed opioid
pain medication and those who use heroin, and other drugs. There is no potential abuse for this
drug (Harm Reduction Coalition, 2018c).
The distribution of Naloxone began at syringe exchanges, but have expanded to other
programs including substance use treatment facilities, Veterans Administration health care
systems, primary care clinics, and pharmacies had all started providing Naloxone to laypersons
(Dunne, 2018). There are 20 states that had no opioid overdose prevention programs that have
been distributed Naloxone and most that who performed overdose reversals were those who used
drugs (Harm Reduction Coalition, 2018c). Providing Naloxone kits to addicts in need reduced
overdose deaths, have been safe, and have been labeled as cost-effective. U.S. and international
health organizations have recommended providing Naloxone kits to individuals who might
witness an opioid overdose (Wheeler, Davidson, Jones, & Irwin, 2015).
DISCUSSION
The purpose of this research paper was to analyze the success of harm reduction programs in
West Virginia in relation to the population of the United States as a whole and to determine if
there has been a HIV and Hepatitis reduction. The primary hypothesis of this study was that
West Virginia did not have a successful harm reduction program in comparison to other states in
the United States. The review suggested that West Virginia has been in fact, behind other states
in the U.S. It was taken into consideration that some states had been working with a harm
reduction program for a longer period of time and also that overdose deaths per capita have been
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higher in West Virginia. Harm reduction programs are sometimes thought of a way to achieve
drug law reform and promote the legalization of drugs, which is not the case.
Utilizing multiple harm reduction programs in West Virginia would also create a
substantial decrease in the number of HIV and Hepatitis virus spread through needle sharing
among injection drug users.
The results of the literature review and the interview with an expert in the field have
suggested that West Virginia falls behind with the success of harm reduction programs in
comparison to other states. The syringe services programs are usually limited to half a day one
day a week at the community health clinics and have caused logistics issues for patients to attend
these locations (Harm Reduction Coalition, 2018d). The literature review supports that harm
reduction programs are a positive thing and should be implemented successfully in states that
have a need for them. There have been several programs throughout West Virginia but the
majority of the population has the mentality that drug use does not happen where they live. West
Virginia’s program was modeled after successful programs in New York, California, and North
Carolina. These states offered an intake and assessment, completed jointly by a harm reduction
specialist and the person who used drugs, to identify the individual´s service needs related to
their use of substances to identify supportive services that can help improve their quality of life
(New York State Department of Health, 2018).
Limitations
This research study was not without its limitations. One barrier was that West Virginia as
a whole does not have support within the state and the counties who have been interested in this
program have been very cautious to implement one, therefore putting up too many barriers to
serve users. Another limitation was that West Virginia’s harm reduction program have been
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relatively new, only existing since 2015, therefore have posed difficulty finding current data and
statistics on the effectiveness of the program. This literature review was restricted due to a small
amount of available articles, which may have affected the quality of the information found
during research. Also, limitations were research and publication bias.
Practical Implications
Continual participation in harm reduction programs in West Virginia and the United
States will continue to save funds, reduce harm in substance use disorder clients, and provide
them with clean injection equipment, linkage to care, and peer recovery coaches (T. Rameriz,
interview, 2018). Support at a state and government level is imperative for a successful harm
reduction program. Utilizing this asset would be favorable for the state moving forward. Rameriz
stated that harm reduction most likely will never return to Kanawha-Charleston Health
Department due to the staff being too overworked to be able to collect accurate data, also more
money and better training would be needed for these types of programs to work efficiently.
There are other entities in the county of Kanawha that are interested in pursuing a similar
program.
CONCLUSION
The benefits of harm reduction programs have continued to address the opioid crisis, overdose
crisis, HIV, and Hepatitis rates, and cannot be overestimated. The United States and West
Virginia need to continue to move forward to fight the drug epidemic taking place. Programs
need to continue to be available to the public, especially in the counties of West Virginia
addressed in this research. Thus, the primary hypothesis and purpose was supported by this
research.
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Number of Cases

DEMOGRAPHICS
Age Range

12-82

Median Age

37

Male

733 (59.8%)

Hospitalizations

646 (52.7%)

Deaths

2
RISK FACTORS

Co-infection with Hepatitis C

620 (62.2%)

Co-infection with Hepatitis B

116 (11.6%)

Reports Illicit Drug Use

832 (78.4%)

Homeless

143 (11.7%)

*Table does not include all reported Hepatitis A cases in the outbreak region; only
those cases that are identified as outbreak-related. Data are provisional and subject to
change.*
Table 1: West Virginia Hepatitis A Outbreak Cases* as of September 14, 2018
Source: West Virginia Department of Health and Human Resources [WV DHHR]. (2018b).
Multistate Outbreak of Hepatitis A. Retrieved from
https://dhhr.wv.gov/oeps/disease/viral-hepatitis/pages/hepA_outbreak.aspx
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Figure 1
Source: West Virginia Department of Health and Human Resources [WV DHHR]. (2018b).
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Figure 2: Conceptual Framework
Source: Michels, I.I., Stover, H. (2012).
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Figure 3: Overview of Literature Evaluation
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APPENDIX
Interview Questions
1. Do you feel that West Virginia is up to speed with their harm reduction programs
compared to other states?
2. Did suspending the syringe exchange program in Kanawha County hurt the harm
reduction program and the individuals it served?
3. How should the program be changed to be more effective?
4. What are/were the strengths and weaknesses of the program?
5. What other states in the United States should be a role model for planning or revamping a
harm reduction program?
6. What is harm reduction to you?
7. What does the future of the harm reduction program in this area and state look like going
forward?
8. How did you get involved with the Kanawha-Charleston Health Department?
9. Does enough support exist in West Virginia for this program?
10. Does the program get support from other states such as question and answer sessions,
meetings, etc?
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